Blog
MariMed Reports Fourth Quarter and Full Year 2024 Earnings The cannabis company reported record revenues and improved adjusted EBITDA.
Georgia Lawmakers Push to Expand State’s Medical Cannabis Program House-passed legislation would remove the terms ‘severe’ and ‘end-state’ from qualifying conditions, while a Senate bill would increase the THC limit.
Patients, Providers, Advocates Gather at NY Capitol, Decry Deterioration of Medical Cannabis Program The advocates are demanding action from elected officials amid dispensary closures curtailing access to medical products unavailable in the adult-use market.
New Jersey Governor Proposes 500% Tax Hike on Cannabis Cultivators as $7 Million Fund Remains Untouched Gov. Phil Murphy proposed that licensed growers pay an additional $200 per pound tax when they sell or transfer products.
Fresh Karma Opens 4th Missouri Dispensary in Columbia The new location joins the company’s existing stores in Parkville, St. Joseph, and Midtown within Kansas City.
MariMed Acquires First State Compassion Center in Delaware The acquisition integrates the Delaware cannabis operator’s cultivation and processing facilities and two dispensaries into MariMed’s operations.
Curaleaf Reports $1.34 Billion in 2024 Revenue The cannabis company also reported an operating cash flow from continuing operations of $163 million and a net loss of $216 million in 2024.
60% of Cannabis Consumed in California Comes From Unregulated Market as Licensed Production Grows The state issued a market outlook report that projects stabilizing prices, an industry value uptick, and growth in the licensed market in 2025.
As California Cannabis Rush Dries Up, Operators Look East The Artist Tree, with nine dispensaries and two lounges, is searching for new opportunities, but there are fewer and fewer places for new stores in California.
Rubicon Organics to Buy MediPharm Labs Cultivation Facility for $4.5 Million The 47,500-square-foot indoor Hope Facility in British Columbia is equipped with advanced cultivation technology.